Lunair Medical
Minneapolis, US · Founded 2023 · Delaware corporation · 1 known investors
Lunair Medical develops an implantable closed-loop system that senses respiration and stimulates the phrenic nerve to treat moderate-to-severe sleep apnea, avoiding masks, mouthpieces, and wearables. The device, currently under investigation, includes a stimulation lead, pulse generator, and titration lead to support automated therapy adjustment and patient management.
Founders & leadership
MC
Mark ChristophersoninExecutive
HL
Howard LevinNamed on SEC filing
Board
PL
DN
David NeustaedterBoard director
MH
Michael HurleyBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$7.5M disclosed across 1 round · 2025
▶$7.5MraisedSep 2025 · 3 investors · Other Health CareRule 506(b)
▶$7.5MraisedSep 2025 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Paul LaVioletteDirector
- Howard LevinDirector
- David NeustaedterDirector
- Michael HurleyDirector
- Mark ChristophersonExecutive Officer, Director
- Offering amount
- $12.5M
- Amount sold
- $7.5M
- First sale
- Aug 2025
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlap
Nuvoair10 shared keywordsNuvoAir provides virtual-first specialty care for patients with complex heart and lung (cardiopulmonary) conditions, offering proactive and continuous remote and in-person care. It serves patients and provider partners with services including virtual or in-person consultations and ongoing care team support.
Inspire Medical8 shared keywordsInspire Medical Systems develops an FDA-approved implantable device that treats obstructive sleep apnea (OSA) by working with the patient's natural breathing, controlled via a small remote and intended for patients for whom CPAP is not effective. The device is surgically placed by an ENT and configured by a sleep medicine professional.
Aluna7 shared keywordsAluna develops a portable respiratory management tool for children with asthma and other chronic respiratory diseases. The device gathers daily health data and transmits it in real time to parents and healthcare providers.
Somnairsleep5 shared keywordsSomnair develops a non-invasive neurostimulation therapy for treating obstructive sleep apnea at home. The device targets the root cause of the condition as a medical treatment for sleep apnea patients.
StimAire5 shared keywordsStimAire develops wearable, wireless, and miniaturized medical solutions for treating obstructive sleep apnea. The company serves patients and combines clinical expertise with device technology in the sleep-medicine space.
Companies competing with Lunair Medical for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Lunair Medical do?
- Lunair Medical develops an implantable closed-loop system that senses respiration and stimulates the phrenic nerve to treat moderate-to-severe sleep apnea, avoiding masks, mouthpieces, and wearables. The device, currently under investigation, includes a stimulation lead, pulse generator, and titration lead to support automated therapy adjustment and patient management.
- Who are Lunair Medical's investors?
- Lunair Medical's investors include SV Health Investors.
- How much funding has Lunair Medical raised?
- Lunair Medical has disclosed $7.5M raised across 1 round.
- Where is Lunair Medical headquartered?
- Lunair Medical is headquartered in Minneapolis, US.